Current report no. 2023/10/2

The BS Biotechna S.A. project entitled “KR2020 – Research and development of a first-in-class drug for use in non-small cell lung cancer” has been positively evaluated by the Polish Agency for Enterprise Development (PARP) as part of call for proposals No. FENG.01.01-IP.02-001/23/2023 (European Funds for a Modern Economy, SMART Path Action). The value of the recommended co-financing is PLN 45,632,070.20.

Link